The drug industry's voice for manufacturing excellence
Production
Development
Information Technology
Compliance
Quality & Risk
Sections
Production
Development
Information Technology
Compliance
Quality & Risk
Facilities
Sectors
Special
Webinars
Podcasts
E-Handbooks
Industry News
Magazine Archives
Contact
Newsletter Subscription
Contact Us
Advertise
Follow us on
https://www.facebook.com/pages/Pharmaceutical-Manufacturing/140261116014887
http://www.linkedin.com/groups?gid=1813799
http://twitter.com/PharmaMfg
Home
Mergers & Acquisitions: Do They Add Value?
From
Knowledge@Wharton
, a podcast/transcription of an
interview with Wharton professor Harbir Singh.
pharmamanufacturing
Jan. 25, 2007
From
Knowledge@Wharton
, a podcast/transcription of an
interview with Wharton professor Harbir Singh.
About the Author
pharmamanufacturing
pharmamanufacturing
Sign up for our eNewsletters
Get the latest news and updates
Sign Up
Related
Fujifilm Biotechnologies to leverage downstream purification system at UK site
Celltrion to buy US biologics manufacturing plant as part of tariff response strategy
Sponsored
Webinar: 2026 Life Sciences Industry Trends: Connecting Quality, Manufacturing, and Asset Management
Sponsored
Accelerating Pharma Digital Transformation: Live Webinar with ISPE
Trending
Eli Lilly plans to invest $6B in new API manufacturing facility in Alabama
Ardena’s US expansion positions the CDMO for growth amid geopolitical uncertainty
Q&A: Inside Cambrex’s expansion, strategic focus in 2025 and beyond
Sponsored Picks
Sponsored
Webinar: 2026 Life Sciences Industry Trends: Connecting Quality, Manufacturing, and Asset Management
Sponsored
Accelerating Pharma Digital Transformation: Live Webinar with ISPE
Sponsored
AI-Powered QMS: The Future of Quality Management
Load More Content